Cleared Traditional

K904789 - SERIES 7000 CARBON DIOXIDE MODULE (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K904789 · Marquette Electronics, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1991
Decision
211d
Days
Class 2
Risk

K904789 is an FDA 510(k) clearance for the SERIES 7000 CARBON DIOXIDE MODULE. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Marquette Electronics, Inc. (Milwaukee, US). The FDA issued a Cleared decision on May 22, 1991 after a review of 211 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Marquette Electronics, Inc. devices

Submission Details

510(k) Number K904789 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 23, 1990
Decision Date May 22, 1991
Days to Decision 211 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 139d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 304
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K904789.
Capnostream™35 Portable Respiratory Monitor (PM35MN)
K253030 · Covidien, LLC · May 2026
Medical Gas Analyzer (AG200)
K250148 · Prior Care Science Technology, Ltd. · Aug 2025
TG-980P CO2 Sensor Kit (TG-980P)
K243956 · Nihon Kohden Corporation · Jun 2025
0184 CO2 Sampling line
K251216 · Barbaras Development, Inc. · Jun 2025
AIM (N/A)
K240937 · Inventeur, LLC · Dec 2024
AirLife™ Open Et Oxygen Mask, AirLife™ Open Et+ Oxygen Mask
K230915 · Vyaire Medical, Inc. · Nov 2024